Literature DB >> 29525841

A brief psychoeducational intervention improves memory contentment in breast cancer survivors with cognitive concerns: results of a single-arm prospective study.

Lori J Bernstein1,2,3, Graham A McCreath4, Joyce Nyhof-Young5, Dilan Dissanayake6, Jill B Rich4.   

Abstract

PURPOSE: One in three breast cancer survivors experiences persistent cognitive changes that can negatively impact daily functioning and quality of life. In our cancer center, the largest tertiary cancer center in Canada, patients with self-reported cancer-related cognitive dysfunction (CRCD) are offered psychoeducation intended to reduce distress about CRCD symptoms and improve everyday cognitive performance, but evidence regarding this intervention's impact is lacking. Here, we assess whether a 1-hour (h), individual psychoeducational intervention designed to promote self-management of CRCD symptoms can improve attitudes and coping with memory-related difficulties in women with breast cancer.
METHODS: Breast cancer survivors with self-reported CRCD (N = 100) were assessed immediately before, immediately after, and 6 weeks following the intervention. Participants' memory contentment, knowledge of CRCD, symptom distress, and self-efficacy to cope with symptoms were measured.
RESULTS: Participants showed improvements in memory contentment immediately after the intervention (Cohen's d effect size and 95% CI = 0.87 [0.58, 1.16]) and 6 weeks later (d = 0.77 [0.48, 1.05]). Significant improvements in secondary study outcomes, including knowledge of CRCD (d = 1.32 [1.01, 1.63]), symptom distress (d = - 0.82 [- 1.11, - 0.53]), and self-efficacy to cope with cognitive symptoms (d = 1.45 [1.14, 1.76]), were also observed.
CONCLUSIONS: A single, 1-hour psychoeducational intervention can achieve lasting and improved adjustment to memory symptoms in breast cancer survivors with self-reported CRCD. Further investigation using a randomized controlled study design is warranted. Comparisons with previously reported psychoeducational interventions for CRCD are made, and next steps for this research are discussed.

Entities:  

Keywords:  Breast cancer; Cancer-related cognitive dysfunction; Chemo-brain; Patient-reported memory symptoms; Psychoeducational intervention; Quality of life

Mesh:

Year:  2018        PMID: 29525841     DOI: 10.1007/s00520-018-4135-z

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  38 in total

1.  Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

Authors:  Tim A Ahles; Andrew J Saykin; Charlotte T Furstenberg; Bernard Cole; Leila A Mott; Karen Skalla; Marie B Whedon; Sarah Bivens; Tara Mitchell; E Robert Greenberg; Peter M Silberfarb
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

2.  Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial.

Authors:  Robert J Ferguson; Brenna C McDonald; Michael A Rocque; Charlotte T Furstenberg; Susan Horrigan; Tim A Ahles; Andrew J Saykin
Journal:  Psychooncology       Date:  2010-12-02       Impact factor: 3.894

Review 3.  Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review.

Authors:  Christie Yao; Lori J Bernstein; Jill B Rich
Journal:  Breast Cancer Res Treat       Date:  2017-07-13       Impact factor: 4.872

4.  Cancer-induced cognitive impairment: practical solutions to reduce and manage the challenge.

Authors:  Janette L Vardy; Victoria J Bray; Haryana M Dhillon
Journal:  Future Oncol       Date:  2017-02-28       Impact factor: 3.404

5.  Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer.

Authors:  Val Shilling; Valerie Jenkins
Journal:  Eur J Oncol Nurs       Date:  2006-07-17       Impact factor: 2.398

6.  Impact of perceived cognitive impairment in breast cancer survivors.

Authors:  Diane Von Ah; Barbara Habermann; Janet S Carpenter; Brandy L Schneider
Journal:  Eur J Oncol Nurs       Date:  2012-08-14       Impact factor: 2.398

Review 7.  Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012.

Authors:  Florence Joly; Bénédicte Giffard; Olivier Rigal; Michiel B De Ruiter; Brent J Small; Martine Dubois; Johan LeFel; Sanne B Schagen; Tim A Ahles; Jeffrey S Wefel; Janette L Vardy; Véronique Pancré; Marie Lange; Hélène Castel
Journal:  J Pain Symptom Manage       Date:  2015-09-05       Impact factor: 3.612

8.  The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.

Authors:  Jeffrey S Wefel; Renato Lenzi; Richard L Theriault; Robert N Davis; Christina A Meyers
Journal:  Cancer       Date:  2004-06-01       Impact factor: 6.860

9.  Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response.

Authors:  Nelli Boykoff; Mona Moieni; Saskia Karen Subramanian
Journal:  J Cancer Surviv       Date:  2009-09-16       Impact factor: 4.442

Review 10.  Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs.

Authors:  Daniël Lakens
Journal:  Front Psychol       Date:  2013-11-26
View more
  5 in total

1.  Pupillary response: cognitive effort for breast cancer survivors.

Authors:  Jamie S Myers; Melike Kahya; Melissa Mitchell; Junqiang Dai; Jianghua He; Sanghee Moon; Kevin Hamilton; Mary Valla; Anne O'Dea; Jennifer Klemp; Monica Kurylo; Abiodun Akinwuntan; Hannes Devos
Journal:  Support Care Cancer       Date:  2018-08-10       Impact factor: 3.603

Review 2.  Psychostimulants for cancer-related cognitive impairment in adult cancer survivors: a systematic review and meta-analysis.

Authors:  Nadia Miladi; Richi Dossa; Maman Joyce Dogba; Marie Immacula Fabienne Cléophat-Jolicoeur; Bruno Gagnon
Journal:  Support Care Cancer       Date:  2019-06-28       Impact factor: 3.603

Review 3.  Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?

Authors:  Sanne B Schagen; Andrey S Tsvetkov; Annette Compter; Jeffrey S Wefel
Journal:  Nat Rev Neurol       Date:  2022-02-09       Impact factor: 44.711

Review 4.  Brain Fog in Hypothyroidism: What Is It, How Is It Measured, and What Can Be Done About It.

Authors:  Mary H Samuels; Lori J Bernstein
Journal:  Thyroid       Date:  2022-05-05       Impact factor: 6.506

Review 5.  The Promise of Nutrient-Derived Bioactive Compounds and Dietary Components to Ameliorate Symptoms of Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors.

Authors:  Nagi B Kumar
Journal:  Curr Treat Options Oncol       Date:  2021-06-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.